Screener

Items To Reconcile Net Income Or Net Loss To Adjusted EBITDA

Name: Adaptive Biotechnologies Items To Reconcile Net Income Or Net Loss To Adjusted EBITDA by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Adaptive Biotechnologies·Business Segments·2 segments

Breakdown

Segment	Q1 '26
Mrd Business	$8.78M
Immune Medicine Business	$5.57M
Total	$8.78M

Segments

Mrd BusinessView metric

Immune Medicine BusinessView metric